Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Neuromolecular Med ; 21(3): 250-261, 2019 09.
Article in English | MEDLINE | ID: mdl-31037465

ABSTRACT

Depression is one of the most prevalent and crucial public health problem connected to significant mortality and co-morbidity. Recently, numerous studies suggested that dietary flavanones exhibit neuroprotective and antidepressant effects against various psycho-physiological conditions including depression. The present study is focused on the antidepressant and neuroprotective effects of naringenin (NAR) and the involvement of sonic hedgehog (Shh) signaling in the chronic unpredictable mild stress (CUMS)-induced depression. Twenty-four male Wistar rats were randomly assigned into four groups: CON group (saline s.c.), NAR group (NAR 50 mg/kg, p.o.), CUMS group (subjected to CUMS along with saline p.o.), and CUMS + NAR group (NAR 50 mg/kg p.o. along with CUMS) for 28 days including 1-week pre-treatment with NAR. The results showed that NAR was found to inhibit behavioral abnormalities including increased despair in force swim test, and reduced locomotor activity caused by CUMS in open field test. Moreover, Morris water maze revealed that NAR also mitigates CUMS-associated cognitive impairment. In addition to the antidepressant-like effect, NAR mitigates morphological anomalies in the hippocampal CA1 region and cortex. Furthermore, we observed brain-derived neurotrophic factor (BDNF), Shh, GLI1, NKX2.2, and PAX6 were downregulated in the hippocampus of CUMS-exposed rats, which can be upregulated by NAR pre-treatment. GLI1 is main downstream signaling component of Shh signaling cascade, which further regulates the expression of homeodomain transcription factors PAX6 and NKX2.2.


Subject(s)
Antidepressive Agents/therapeutic use , Depression/drug therapy , Flavanones/therapeutic use , Hedgehog Proteins/physiology , Learning Disabilities/drug therapy , Memory Disorders/drug therapy , Neuroprotective Agents/therapeutic use , Signal Transduction/drug effects , Stress, Psychological/drug therapy , Zinc Finger Protein GLI1/physiology , Animals , Antidepressive Agents/pharmacology , Chronic Disease , Depression/etiology , Depression/metabolism , Depression/prevention & control , Disease Models, Animal , Drug Evaluation, Preclinical , Exploratory Behavior/drug effects , Flavanones/pharmacology , Gene Expression Regulation/drug effects , Hippocampus/chemistry , Hippocampus/drug effects , Homeobox Protein Nkx-2.2 , Learning Disabilities/etiology , Learning Disabilities/metabolism , Learning Disabilities/prevention & control , Male , Maze Learning/drug effects , Memory Disorders/etiology , Memory Disorders/metabolism , Memory Disorders/prevention & control , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/genetics , Neuroprotective Agents/pharmacology , Random Allocation , Rats , Rats, Wistar , Stress, Psychological/physiopathology , Swimming
SELECTION OF CITATIONS
SEARCH DETAIL
...